Serial Convalescent Plasma Infusions for the Initial COVID-19 Infections in the Appalachian Region of West Virginia

PURPOSE: The rapid spread of SARS-CoV-2, the virus that is responsible for causing COVID-19, has presented the medical community with another example of when convalescent plasma (CP) is still used today. The ability to standardize CP at the onset of a pandemic is unlikely to exist in a reliable and...

Descripción completa

Detalles Bibliográficos
Autores principales: Peppers, Brian P., Shmookler, Aaron, Stanley, Johnathan, Giblin Sutton, Lisa, Perrotta, Peter L., Kieffer, Theodore, Skoner, David, Mahady, Stacey, Lewandrowski, Callum, Damron, Heath, Horspool, Alexander, Sakhjua, Ankit, McCarthy, Paul, Hostoffer, Robert W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252015/
https://www.ncbi.nlm.nih.gov/pubmed/35795339
http://dx.doi.org/10.1177/21526575221110488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252015/
https://www.ncbi.nlm.nih.gov/pubmed/35795339
http://dx.doi.org/10.1177/21526575221110488

Ejemplares similares